DELAYED PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS TREATED WITH TTFIELDS: A REPORT OF TWO CASES

被引：0
|
作者：
Saito, Norihiko [1 ]
Hirai, Nozomi [1 ]
Yagihashi, Akinori [2 ]
Takahagi, Shusaku [2 ]
Kushida, Naoki [1 ]
Sato, Sho [1 ]
Hiramoto, Yu [1 ]
Fujita, Satoshi [1 ]
Nakayama, Haruo [1 ]
Haya, Morito [1 ]
Sakurai, Takatoshi [1 ]
Iwabuchi, Satoshi [1 ]
机构：
[1] Toho Univ, Ohashi Med Ctr, Tokyo, Japan
[2] Ishii Hosp Neurosurg, Fukushima, Japan
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NIMG-34
引用
收藏
页码：136 / 136
页数：1
相关论文
共 50 条
  • [31] HISTOLOGY OF RADIATION-INDUCED PSEUDOPROGRESSION WITH MULTIPLE FOCI IN TREATED GLIOBLASTOMA
    Banerjee, Somdeb
    Tran, Di
    Trevino, Christopher
    NEURO-ONCOLOGY, 2022, 24 : 160 - 160
  • [32] THE IMPACT OF EXTENT OF RESECTION ON THE OCCURRENCE OF PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS
    Chang, J.
    Park, H.
    Roh, T.
    Moon, J.
    Kim, E.
    Kang, S.
    Kim, S.
    Ahn, S.
    Cho, J.
    Suh, C.
    NEURO-ONCOLOGY, 2016, 18 : 55 - 56
  • [33] The influence of endothelial hyperplasia on pseudoprogression development in patients with glioblastoma
    Petrovic, Marko
    Ilic, Rosanda
    Milicevic, Mihailo
    Peulic, Miodrag
    Grujicic, Danica
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2019, 147 (5-6) : 311 - 315
  • [34] TemozolomideDecreased platelet count and glioblastoma multiforme pseudoprogression: case report
    Reactions Weekly, 2023, 1954 (1) : 403 - 403
  • [35] FIRST REPORT ON THE COMBINATION OF AXITINIB AND TUMOR TREATING FIELDS (TTFIELDS) IN THREE PATIENTS WITH RECURRENT GLIOBLASTOMA
    Kessler, A. F.
    Weiland, J.
    Linsenmann, T.
    Ernestus, R.
    Hagemann, C.
    Loehr, M.
    NEURO-ONCOLOGY, 2019, 21 : 73 - 73
  • [36] Characterization of pseudoprogression in patients with glioblastoma: Is histology the gold standard?
    Melguizo, I.
    Bruner, J.
    Guha-Thakurta, N.
    Hess, K. R.
    Puduvalli, V. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [37] Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?
    Melguizo-Gavilanes, Isaac
    Bruner, Janet M.
    Guha-Thakurta, Nandita
    Hess, Kenneth R.
    Puduvalli, Vinay K.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 123 (01) : 141 - 150
  • [38] FREQUENCY OF PSEUDOPROGRESSION IN PATIENTS WITH GLIOBLASTOMA ACCORDING TO RANO CRITERIA
    Radbruch, A.
    Fladt, J.
    Wiestler, B.
    Baeumer, P.
    Heiland, S.
    Wick, W.
    Bendszus, M.
    NEURO-ONCOLOGY, 2012, 14 : 37 - 37
  • [39] Demyelinating polyradiculoneuropathy in patients with metastatic melanoma treated with nivolumab: report of two cases
    De Rojas Leal, C.
    Pinel Rios, F.
    Leon Plaza, O.
    Delgado Gil, V.
    Gomez Heredia, M. J.
    Del Pilar Carbonell Corvillo, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 541 - 542
  • [40] Pattern dystrophies in patients treated with deferoxamine: report of two cases and review of the literature
    Georgakopoulos, Constantine D.
    Tsapardoni, Foteini
    Kostopoulou, Elli V.
    Makri, Olga E.
    BMC OPHTHALMOLOGY, 2018, 18
12345